Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells
- PMID: 12839924
Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells
Abstract
The Hepatitis B Virus X (HBx) protein of hepatitis B virus plays a major role in hepatocellular carcinoma. It has been reported that the mutation and disruption of PTEN, a known tumor suppressor and a negative regulator of phosphatidylinositol 3'-kinase/AKT might be involved in tumor progression. However, the relationship between HBx and PTEN expression in hepatocellular carcinoma (HCC) development is not fully understood. This study reports on an investigation of whether PTEN expression in HBx-transfected cells is modulated by HBx or not. HBx decreased the expression of PTEN in HBx-transfected cells, as evidenced by Western as well as Northern blot analysis. In addition, AKT was found to be activated by HBx, as evidenced by not only the phosphorylation of AKT at serine 473 but by the phosphorylation of the exogenous substrate histone H2B as well, and these were specifically blocked by the presence of wortmannin. Moreover, The growth rate of HBx-transfected liver cells was higher than that of Chang and Chang-pEGFP cells. HBx had no effect on the expression of p53, a known transcriptional activator of PTEN. However, we confirmed that the binding of the p53 protein to p53 binding site-oligo of PTEN promoter is decreased in HBx-transfected liver cells by electrophoretic mobility shift analysis and, in addition, that HBx disrupts p53-mediated PTEN transcription, as evidenced by a PTEN promoter assay. Therefore, we conclude that HBx in liver cells down-regulates the expression of PTEN and activates AKT. This constitutes the first report to demonstrate that HBx has an effect on the p53-mediated transcription of PTEN, which, in turn, is associated with tumor suppression.
Similar articles
-
PTEN modulates hepatitis B virus-X protein induced survival signaling in Chang liver cells.Virus Res. 2006 Dec;122(1-2):53-60. doi: 10.1016/j.virusres.2006.06.010. Epub 2006 Jul 25. Virus Res. 2006. PMID: 16872708
-
MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.J Transl Med. 2016 May 5;14(1):122. doi: 10.1186/s12967-016-0888-7. J Transl Med. 2016. PMID: 27150195 Free PMC article.
-
Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.FASEB J. 2004 Jul;18(10):1123-5. doi: 10.1096/fj.03-1429fje. Epub 2004 May 7. FASEB J. 2004. PMID: 15132991
-
Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:144-52. doi: 10.1111/j.1440-1746.2010.06546.x. J Gastroenterol Hepatol. 2011. PMID: 21199526 Review.
-
Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.World J Gastroenterol. 2015 May 28;21(20):6317-28. doi: 10.3748/wjg.v21.i20.6317. World J Gastroenterol. 2015. PMID: 26034368 Free PMC article. Review.
Cited by
-
Role of miR-148a in hepatitis B associated hepatocellular carcinoma.PLoS One. 2012;7(4):e35331. doi: 10.1371/journal.pone.0035331. Epub 2012 Apr 9. PLoS One. 2012. PMID: 22496917 Free PMC article.
-
Computational identification of bioactive compounds from Cydonia oblonga Mill. against hepatocellular carcinoma by targeting pTEN and HBx-interacting protein.J Mol Model. 2022 Jun 17;28(7):191. doi: 10.1007/s00894-022-05170-3. J Mol Model. 2022. PMID: 35711004
-
Hidden secret in hepatitis B viral X protein mutation and hypoxia-inducible factor-1α in hepatocarcinoma cancer.Hepatobiliary Surg Nutr. 2014 Jun;3(3):115-7. doi: 10.3978/j.issn.2304-3881.2014.02.14. Hepatobiliary Surg Nutr. 2014. PMID: 25019072 Free PMC article.
-
The Mechanisms of HBV-Induced Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2021 May 20;8:435-450. doi: 10.2147/JHC.S307962. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34046368 Free PMC article. Review.
-
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.Aging (Albany NY). 2011 Mar;3(3):192-222. doi: 10.18632/aging.100296. Aging (Albany NY). 2011. PMID: 21422497 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Research Materials
Miscellaneous